Listen Presentations & Publications Share Facebook Linkedin Twitter Whatsapp Email Axiomer technology Axiomer RNA editing technology Download link TIDES US (2025) Beal Axiomer platform pdf, 1.64 MB Download link ASGCT (2025) Platenburg NTCP (abstract 333) pdf, 1.68 MB Download link ASGCT (2025) Platenburg et al., PNPLA3-I148M (abstract 1654) pdf, 1.44 MB Download link ASGCT (2025) Platenburg et al., MECP2 for Rett Syndrome (abstract 1645) pdf, 1.37 MB Download link GRC RNA Editing (2025) Platenburg Exploring ADAR RNA editing therapeutic applications pdf, 2.39 MB Download link ProQR Investor & Analyst Event 2024 Presentation pdf, 17.77 MB Download link OTS (2024) Gerard Platenburg Platenburg 2024 OTS - Oligonucleotide guided editing of NTCP for cholestatic diseases pdf, 1.54 MB Download link RNA Editing Summit (2024) Developing Axiomer RNA Editing Technology Towards Clinical Development pdf, 2.83 MB External link ASGCT (2024) Partnership poster, Lilly, Complex Metabolism and Prolonged PK/PD of a GalNAc-Conjugated Editing Oligonucleotide (EON) in Mice External link ASGCT (2024) Gerard Platenburg et al., Robust and Durable RNA Editing In Vivo with Axiomer Editing Oligonucleotides in Non Human Primates External link Deaminet (2024) Gerard Platenburg, Axiomer an RNA editing technology External link RNA Editing Summit (2023) Harnessing chemical modifications to improve ADAR potency and unlock Axiomer broad applicability Internal link DATS (2023) Monica Aguila, Exploring the potential of new RNA editing technologies leveraging ADAR endogenous machinery Internal link TIDES USA (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders Internal link Analyst & Investor Axiomer Technology R&D Event (2023) Internal link GRC (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides to Address Liver Originated Disorders Internal link OPT Congress (2023) Gerard Platenburg, Therapeutic potential of an RNA editing platform using Editing Oligonucleotides (EONs) Internal link TIDES Europe (2022) Gerard Platenburg, Progress on Development of RNA Base Editing Technologies for Precision Medicines Internal link TIDES USA (2022) Gerard Platenburg, Development of RNA Base Editing Technologies for Precision Medicines Download link Axiomer™ Technology Overview pdf, 2.25 MB Internal link JACS (2021) Erin E. Doherty et al., Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position Internal link OTS (2018) Julien Boudet et al., Structure-based computational approach for optimizing oligonucleotides for A-to-I editing Internal link TIDES EU (2018) Antti Aalto, Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes Share page Facebook Linkedin Twitter Whatsapp Email
Download link GRC RNA Editing (2025) Platenburg Exploring ADAR RNA editing therapeutic applications pdf, 2.39 MB
Download link OTS (2024) Gerard Platenburg Platenburg 2024 OTS - Oligonucleotide guided editing of NTCP for cholestatic diseases pdf, 1.54 MB
Download link RNA Editing Summit (2024) Developing Axiomer RNA Editing Technology Towards Clinical Development pdf, 2.83 MB
